Literature DB >> 18419413

Changing varicella epidemiology in active surveillance sites--United States, 1995-2005.

Dalya Guris1, Aisha O Jumaan, Laurene Mascola, Barbara M Watson, John X Zhang, Sandra S Chaves, Paul Gargiullo, Dana Perella, Rachel Civen, Jane F Seward.   

Abstract

Significant reductions in varicella incidence were reported from 1995 to 2000 in the varicella active surveillance sites of Antelope Valley (AV), California, and West Philadelphia (WP), Pennsylvania. We examined incidence rates, median age, and vaccination status of case patients for 1995-2005. Coverage data were from the National Immunization Survey. By 2005, coverage among children 19-35 months of age reached 92% (AV) and 94% (WP); 57% and 64% of case patients in AV and WP, respectively, were vaccinated; and varicella incidence declined by 89.8% in AV and 90.4% in WP. Incidence declined in all age groups, especially among children <10 years of age in both sites and among adolescents 10-14 years of age in WP. In AV, since 2000, the incidence among adolescents 10-14 and 15-19 years of age increased. Implementation of school requirements through 10th grade in WP may explain the differences in the decline in incidence among adolescents. Continued surveillance will be important to monitor the impact that the 2-dose vaccine policy in children has on varicella epidemiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18419413     DOI: 10.1086/522156

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  57 in total

1.  Varicella zoster virus transmission in the vaccine era: unmasking the role of herpes zoster.

Authors:  Karen C Bloch; James G Johnson
Journal:  J Infect Dis       Date:  2012-03-27       Impact factor: 5.226

Review 2.  New insights into rotavirus vaccines.

Authors:  Chiara Mameli; Valentina Fabiano; Gian Vincenzo Zuccotti
Journal:  Hum Vaccin Immunother       Date:  2012-08-01       Impact factor: 3.452

3.  Varicella-related hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era.

Authors:  Adriana S Lopez; John Zhang; Cedric Brown; Stephanie Bialek
Journal:  Pediatrics       Date:  2011-01-03       Impact factor: 7.124

4.  Effectiveness of 2 doses of varicella vaccine in children.

Authors:  Eugene D Shapiro; Marietta Vazquez; Daina Esposito; Nancy Holabird; Sharon P Steinberg; James Dziura; Philip S LaRussa; Anne A Gershon
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

5.  Varicella vaccination programs do not seem to shift the age of disease to older age groups.

Authors:  Manuel García Cenoz
Journal:  Transl Pediatr       Date:  2014-10

6.  Incidence and consequences of varicella in children treated for cancer in Guatemala.

Authors:  Amy E Caruso Brown; Edwin J Asturias; Mario Melgar; Federico A Antillon-Klussmann; Pamela Mettler; Myron J Levin
Journal:  World J Pediatr       Date:  2016-06-29       Impact factor: 2.764

Review 7.  Successes and challenges in varicella vaccine.

Authors:  Orestis Papaloukas; Georgia Giannouli; Vassiliki Papaevangelou
Journal:  Ther Adv Vaccines       Date:  2014-03

8.  Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.

Authors:  Murli U Purswani; Brad Karalius; Tzy-Jyun Yao; D Scott Schmid; Sandra K Burchett; George K Siberry; Kunjal Patel; Russell B Van Dyke; Ram Yogev; Robert H Lurie; Ram Yogev; Margaret Ann Sanders; Kathleen Malee; Scott Hunter; William Shearer; Mary Paul; Norma Cooper; Lynnette Harris; Murli Purswani; Mahboobullah Baig; Anna Cintron; Ana Puga; Sandra Navarro; Patricia Garvie; James Blood; Sandra Burchett; Nancy Karthas; Betsy Kammerer; Andrew Wiznia; Marlene Burey; Molly Nozyce; Arry Dieudonne; Linda Bettica; Susan Adubato; Janet Chen; Maria Garcia Bulkley; Latreaca Ivey; Mitzie Grant; Katherine Knapp; Kim Allison; Megan Wilkins; Midnela Acevedo-Flores; Heida Rios; Vivian Olivera; Margarita Silio; Medea Jones; Patricia Sirois; Stephen Spector; Kim Norris; Sharon Nichols; Elizabeth McFarland; Alisa Katai; Jennifer Dunn; Suzanne Paul; Gwendolyn Scott; Patricia Bryan; Elizabeth Willen
Journal:  Clin Infect Dis       Date:  2015-09-18       Impact factor: 9.079

Review 9.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

10.  Varicella: epidemiological aspects and vaccination coverage in the Veneto Region.

Authors:  Vincenzo Baldo; Tatjana Baldovin; Francesca Russo; Marta Cecilia Busana; Cinzia Piovesan; Greta Bordignon; Aurore Giliberti; Renzo Trivello
Journal:  BMC Infect Dis       Date:  2009-09-08       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.